Gene · 10803
Papers2,788
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,788
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ageing affects the CD4+ T cell polarization and mucosal tropism induced by TLR2/TLR4-activated dendritic cells. | J Leukoc Biol | 2025 | 40576094 | PubTator, text mining | PubMed |
| Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer. | Mol Oncol | 2025 | 40434951 | PubTator, text mining | PubMed |
| Tamibarotene-Loaded Nanoemulsion Incorporating Toll-like Receptor 2/6 Agonist as an Intramuscular Adjuvant System Enhances Gastrointestinal Mucosal Immunity. | ACS Nano | 2025 | 40376869 | PubTator, text mining | PubMed |
| Analysis of Gut-Homing Receptors in Circulating Mucosal-Associated Invariant T Cells and Their Presence in Synovial Tissue From Patients With Axial Spondyloarthritis. | J Rheumatol | 2025 | 40374518 | PubTator, text mining | PubMed |
| Elucidating Immune Cell Changes in Celiac Disease: Revealing New Insights from Spectral Flow Cytometry. | Int J Mol Sci | 2025 | 40243487 | PubTator, text mining | PubMed |
| Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia. | Sci Transl Med | 2025 | 40238916 | PubTator, text mining | PubMed |
| Adenosine-generating CD39+ plasmablasts predispose to successful infliximab therapy in pediatric IBD. | Life Sci Alliance | 2025 | 40199584 | PubTator, text mining | PubMed |
| Signal termination of the chemokine receptor CCR9 is governed by an arrestin-independent phosphorylation mechanism. | J Biol Chem | 2025 | 40154615 | PubTator, text mining | PubMed |
| 16S rRNA and transcriptome analysis revealed the regulatory mechanism of Romboutsia lituseburensis on serum immunoglobulin levels in geese. | Poult Sci | 2025 | 40086254 | PubTator, text mining | PubMed |
| Sequential activation of conventional and plasmacytoid dendritic cells in autoimmune pancreatitis and systemic lupus erythematosus: similarities and dissimilarities. | Front Immunol | 2025 | 40040712 | PubTator, text mining | PubMed |
| Transformer Decoder Learns from a Pretrained Protein Language Model to Generate Ligands with High Affinity. | J Chem Inf Model | 2025 | 39871540 | PubTator, text mining | PubMed |
| Optimal chemokine receptors for enhancing immune cell trafficking in adoptive cell therapy. | Immunol Res | 2025 | 39815137 | PubTator, text mining | PubMed |
| Sexual dimorphism in lung transcriptomic adaptations in fetal alcohol spectrum disorders. | Respir Res | 2025 | 39780208 | PubTator, text mining | PubMed |
| Alterations in Circulating T-Cell Subsets with Gut-Homing/Residency Phenotypes Predict HIV-1 Status and Subclinical Atherosclerosis. | bioRxiv | 2025 | 39651272 | PubTator, text mining | PubMed |
| TRIM29 controls enteric RNA virus-induced intestinal inflammation by targeting NLRP6 and NLRP9b signaling pathways. | Mucosal Immunol | 2025 | 39396665 | PubTator, text mining | PubMed |
| The pathogenesis of IgA nephropathy and implications for treatment. | Nat Rev Nephrol | 2025 | 39232245 | PubTator, text mining | PubMed |
| Lifestyle Intervention Modulates the CD4+ T Cell Profile in the Blood of Crohn's Disease Patients. | Inflamm Bowel Dis | 2025 | 39102712 | PubTator, text mining | PubMed |
| Advancing therapeutic frontiers: a pipeline of novel drugs for luminal and perianal Crohn's disease management. | Ther Adv Gastroenterol | 2024 | 39711916 | PubTator, text mining | PubMed |
Idiosyncratic Hepatocellular Drug-Induced Liver Injury by Flucloxacillin with Evidence Based on Roussel Uclaf Causality Assessment Method and HLA B*57:01 Genotype: From Metabolic CYP 3A4/3A7 to Immune Mechanisms. | Biomedicines | 2024 | 39457521 | PubTator, text mining | PubMed |
| Relationship between CCL25/CCR9 Levels in Follicular Fluid and High Ovarian Response in Patients with Polycystic Ovary Syndrome. | Int J Endocrinol | 2024 | 39411316 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10803/papers?page=5